SUMMITSEC price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- SUMMITSEC
- MB Code
- MBEQU2093
- ISIN
- INE519C01017
- BSE code
- 533306
- Industry group
- Finance
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 11.43 Cr
- Net profit
- -23.24 Cr
- EPS
- -21.31
- YoY revenue
- +16.51%
Company documents
6 PDFs across 2 categories
Audited annual reports & financial statements
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for SUMMITSEC
Market sentiment in September is expected to remain volatile following the Modi-Xi meeting and the SCO Summit 2025, according to Prashant…
Gift Nifty traded at 24,759, a 30-point premium over Nifty futures' previous close, signaling a positive start for Indian stock market in…
AstraZeneca is in advanced talks for a $15 billion oncology licensing deal, highlighting its position as a leading high-growth stock, acc…
Summit Therapeutics and AstraZeneca are in talks for a potential partnership deal valued at up to $15 billion, according to Bloomberg News.
Price returns
Historical performance
Technicals
Indicator consensus